Richard T Epperson Selected Research

norspermidine

1/2019

In vivo analysis of a first-in-class tri-alkyl norspermidine-biaryl antibiotic in an active release coating to reduce the risk of implant-related infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard T Epperson Research Topics

Disease

3	Wounds and Injuries (Trauma) 12/2021 - 01/2019
2	Infections 01/2019 - 11/2012
1	Bone Fractures (Bone Fracture) 02/2019

Drug/Important Bio-Agent (IBA)

1	Explosive Agents (Explosives)IBA 12/2021
1	MetalsIBA 02/2019
1	SiliconesIBA 01/2019
1	norspermidineIBA 01/2019
1	AlloysIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	titanium niobium nitrideIBA 01/2019
1	SteroidsIBA 11/2012

Therapy/Procedure

1	Tourniquets 02/2019